These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21699491)

  • 1. Has selenium a chemopreventive effect on hepatocellular carcinoma?
    Costantini S; Lepore MG; Castello G; Colonna G
    Mini Rev Med Chem; 2011 Jun; 11(7):599-610. PubMed ID: 21699491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium in the prevention and treatment of hepatocellular carcinoma.
    Darvesh AS; Bishayee A
    Anticancer Agents Med Chem; 2010 May; 10(4):338-45. PubMed ID: 20380634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and liver cancer: a review.
    Darvesh AS; Aggarwal BB; Bishayee A
    Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
    Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
    Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats.
    Ahmed HH; Khalil WK; Hamza AH
    Toxicol Mech Methods; 2014 Dec; 24(8):593-602. PubMed ID: 25156538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
    Mastron JK; Siveen KS; Sethi G; Bishayee A
    Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keap1 eye on the target: chemoprevention of liver cancer.
    Yates MS; Kensler TW
    Acta Pharmacol Sin; 2007 Sep; 28(9):1331-42. PubMed ID: 17723167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.
    Bishayee A; Thoppil RJ; Waghray A; Kruse JA; Novotny NA; Darvesh AS
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1191-232. PubMed ID: 22873222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytosterols and Triterpenoids for Prevention and Treatment of Metabolic-related Liver Diseases and Hepatocellular Carcinoma.
    Sánchez-Crisóstomo I; Fernández-Martínez E; Cariño-Cortés R; Betanzos-Cabrera G; Bobadilla-Lugo RA
    Curr Pharm Biotechnol; 2019; 20(3):197-214. PubMed ID: 30806308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.
    Darvesh AS; Bishayee A
    Nutr Cancer; 2013; 65(3):329-44. PubMed ID: 23530632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of environmental factors in the etiology of hepatocellular carcinoma].
    Tornai I
    Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished CCl
    Elkhamesy A; Refaat M; Gouida MSO; Alrdahe SS; Youssef MM
    J Food Biochem; 2022 Apr; 46(4):e13845. PubMed ID: 34231234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer.
    Wu BK; Chen QH; Pan D; Chang B; Sang LX
    Int Immunopharmacol; 2021 Jul; 96():107790. PubMed ID: 34162153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium and other antioxidants for chemoprevention of gastrointestinal cancers.
    Jayaprakash V; Marshall JR
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):507-18. PubMed ID: 22122767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.
    Hoshida Y; Fuchs BC; Tanabe KK
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1129-59. PubMed ID: 22873223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive activity of a macrofungus Phellinus rimosus against N-nitrosodiethylamine induced hepatocellular carcinoma in rat.
    Ajith TA; Janardhanan KK
    J Exp Ther Oncol; 2006; 5(4):309-21. PubMed ID: 17024971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives.
    Bimonte S; Albino V; Piccirillo M; Nasto A; Molino C; Palaia R; Cascella M
    Drug Des Devel Ther; 2019; 13():611-621. PubMed ID: 30858692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism?
    Irmak MB; Ince G; Ozturk M; Cetin-Atalay R
    Cancer Res; 2003 Oct; 63(20):6707-15. PubMed ID: 14583465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on chemoprevention of hepatocellular carcinoma by ginseng: an introduction to the protocol.
    Ginseng-HCC Chemopreventive Study Osaka Group.
    J Korean Med Sci; 2001 Dec; 16 Suppl(Suppl):S70-4. PubMed ID: 11748380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.